The protein VGLL4 controls both Paneth cell development and defensin production in the gut, and its loss leads to fewer antimicrobial peptides, microbiome imbalance, and impaired intestinal repair.
VGLL4 reduced in human colitisBeyond mouse experiments, public gene expression datasets from human colitis patients also show reduced VGLL4 — suggesting this antimicrobial peptide regulatory pathway may fail in inflammatory bowel disease.
What the researchers found
The protein VGLL4 is essential for Paneth cell function and antimicrobial peptide production in the gut. When VGLL4 was deleted from intestinal epithelium, mice had fewer Paneth cells, produced less antimicrobial peptides (including defensins), developed gut microbiome imbalances (dysbiosis), and had impaired intestinal regeneration capacity.
The study identified two distinct mechanisms: VGLL4 teams up with TEAD4 and ATOH1 to drive Paneth cell differentiation via GFI1, and separately forms a complex with TEAD4 and TCF4 to directly induce defensin expression. Notably, VGLL4 expression drops during irradiation injury and DSS-induced colitis, and human colitis datasets also show reduced VGLL4 — suggesting this pathway may be compromised in inflammatory bowel disease.
Why it matters
Paneth cells are the gut's antimicrobial peptide factories — they produce defensins and other peptides that keep gut bacteria in check and maintain the stem cell niche. Discovering that VGLL4 controls both Paneth cell numbers and defensin production provides a new upstream target for understanding and potentially treating conditions where gut antimicrobial defense breaks down, including inflammatory bowel disease.
The numbers in context
VGLL4 knockout in intestinal epithelium · Reduced Paneth cell numbers · Decreased AMP/defensin production · Microbiota dysbiosis · Impaired regeneration · VGLL4 reduced in human colitis datasets
How the study worked
Conditional knockout mouse study deleting VGLL4 from intestinal epithelium. Researchers analyzed Paneth cell numbers, antimicrobial peptide expression, gut microbiome composition, and intestinal regeneration capacity. Molecular mechanisms were dissected through protein complex analysis (VGLL4-TEAD4-ATOH1 and VGLL4-TEAD4-TCF4). Human colitis gene expression datasets were used for clinical validation.
Who was studied
Conditional VGLL4 knockout mice; human colitis gene expression datasets for validation
What this study cannot tell us
Primarily a mouse study — direct translation to human gut defense requires caution. The human colitis data is correlational (reduced VGLL4 expression) without functional validation in human tissue. The specific antimicrobial peptides affected and the degree of microbiome disruption are not fully quantified in the abstract.
How to read the evidence
Rated low-moderate: rigorous conditional knockout mouse study with clear mechanistic dissection and human correlational data. However, no functional human tissue experiments were performed, and the clinical implications remain theoretical.
When this study was published
Published in 2026. This is a very recent study identifying a novel regulatory pathway for gut antimicrobial peptide production.
The bigger picture
Antimicrobial peptide deficiency in the gut has been implicated in Crohn's disease and other inflammatory bowel conditions. This study identifies VGLL4 as an upstream master regulator — a single point that controls both the cells that make antimicrobial peptides and the peptides themselves. Finding such regulatory nodes is valuable because they could become therapeutic targets for restoring gut antimicrobial defense in diseases where it's compromised.
Questions still open
- Could restoring VGLL4 activity in the gut reverse Paneth cell deficiency and defensin loss in inflammatory bowel disease?
- Is reduced VGLL4 a cause or consequence of colitis, and does it precede disease onset?
- Are there ways to pharmacologically boost VGLL4 expression to strengthen gut antimicrobial peptide defenses?
Common questions
What are Paneth cells and why do they matter?
What does VGLL4 have to do with antimicrobial peptides?
Read the original research
VGLL4 modulates Paneth cells and sustains intestinal homeostasis.
EMBO reports
Citation
Zhang, Haoen; Wang, Zuoyun; Wang, Xiaodong; Yu, Wentao; Zhang, Guoying; Zhang, Haijiao; Lu, Yi; Sun, Yang; Lu, Tiantian; Li, Xiaoyu; Yang, Ruizeng; Sun, Jiaqi; Xu, Jinjin; Huang, Shuo; Ma, Xueyan; Ren, Jiale; Tang, Nan; Cheng, Zhonghua; Yu, Jing; Wei, Fang; Zhou, Hu; Li, Jinsong; Qin, Jun; Jin, Yunyun; Zhang, Lei. (2026). VGLL4 modulates Paneth cells and sustains intestinal homeostasis.. EMBO reports. https://doi.org/10.1038/s44319-026-00699-3